drugset / Trial / NCT03208101
A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults
RandomizedParallel-groupOpen-labelPrevention
Summary
This is a single-center, randomized, active-controlled, parallel-group, open-label, phase I study to evaluate safety and immunogenicity of single injection of LBVD or Eupenta co-administered with Imovax Polio in healthy adults.
Timeline
- Start
- 2017-07-03
- Primary completion
- 2017-09-06
- Completion
- 2017-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DTP-HepB-Hib vaccine | Vaccine | — | — |
| Subject | DTP-HepB-IPV-Hib vaccine | Vaccine | — | — |
| Comparator | IPV | Vaccine | — | — |